Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study

The Lancet

Volumn 388, Issue 10046, 2016, Pages 761-775

  O'Donnell, Martin J ^a,b   Chin, Siu Lim ^a   Rangarajan, Sumathy ^a   Xavier, Denis ^c   Liu, Lisheng ^d   Zhang, Hongye ^e   Rao Melacini, Purnima ^a   Zhang, Xiaohe ^a   Pais, Prem ^c   Agapay, Steven ^a   Lopez Jaramillo, Patricio ^f   Damasceno, Albertino ^g   Langhorne, Peter ^h   McQueen, Matthew J ^a   Rosengren, Annika ⁱ   Dehghan, Mahshid ^a   Hankey, Graeme J ^j   Dans, Antonio L ^k   Elsayed, Ahmed ^l   Avezum, Alvaro ^m   Mondo, Charles ⁿ   Diener, Hans Christoph ^o   Ryglewicz, Danuta ^p   Czlonkowska, Anna ^p   Pogosova, Nana ^q   Weimar, Christian ^o   Iqbal, Romaina ^r   Diaz, Rafael ^s   Yusoff, Khalid ^t,u   Yusufali, Afzalhussein ^v   Oguz, Aytekin ^w   Wang, Xingyu ^e   Penaherrera, Ernesto ^x   Lanas, Fernando ^y   Ogah, Okechukwu S ^z   Ogunniyi, Adesola ^z   Iversen, Helle K ^aa   Malaga, German ^ab   Rumboldt, Zvonko ^ac   Oveisgharan, Shahram ^ad   Al Hussain, Fawaz ^ag   Magazi, Daliwonga ^ae   Nilanont, Yongchai ^af   Ferguson, John ^b   Pare, Guillaume ^a   Yusuf, Salim ^a   more..

^a HAMILTON HEALTH SCIENCES   (Canada)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^d State Key Laboratory of Cardiovascular Disease Department of Pathology National Center for Cardiovascular Disease   (China)

^e Beijing Hypertension League Institute   (China)

^f UNIVERSIDAD DE SANTANDER   (Colombia)

^g EDUARDO MONDLANE UNIVERSITY   (Mozambique)

^h UNIVERSITY OF GLASGOW   (United Kingdom)

ⁱ SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^j UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^k UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^l ALZAIEM ALAZHARI UNIVERSITY   (Sudan)

^m INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

ⁿ MULAGO HOSPITAL   (Uganda)

^o UNIVERSITY HOSPITAL ESSEN   (Germany)

^p INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^q NATIONAL MEDICAL RESEARCH CENTER FOR THERAPY AND PREVENTIVE MEDICINE   (Russian Federation)

^r AGA KHAN UNIVERSITY   (Pakistan)

^s Estudios Clínicos Latino América and Instituto Cardiovascular de Rosario   (Argentina)

^t UNIVERSITI TEKNOLOGI MARA   (Malaysia)

^u UCSI UNIVERSITY   (Malaysia)

^v DUBAI HEALTH AUTHORITY   (United Arab Emirates)

^w ISTANBUL MEDENIYET UNIVERSITY   (Turkey)

^x HOSPITAL LUIS VERNAZA   (Ecuador)

^y UNIVERSIDAD DE LA FRONTERA   (Chile)

^z UNIVERSITY OF IBADAN   (Nigeria)

^aa UNIVERSITY OF COPENHAGEN   (Denmark)

^ab UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^ac UNIVERSITY OF SPLIT   (Croatia)

^ad RUSH UNIVERSITY MEDICAL CENTER   (United States)

^ae UNIVERSITY OF LIMPOPO   (South Africa)

^af MAHIDOL UNIVERSITY   (Thailand)

^ag KING SAUD UNIVERSITY   (Saudi Arabia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HEMOGLOBIN A1C; APOA1 PROTEIN, HUMAN; BIOLOGICAL MARKER;

ADULT; AFRICA; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; ASIA; ASSESSMENT OF HUMANS; ATTRIBUTABLE RISK; AUSTRALIA; BLOOD SAMPLING; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; EUROPE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; MIDDLE EAST; MODIFIED ALTERNATIVE HEALTHY EATING INDEX; PHYSICAL ACTIVITY; POPULATION ATTRIBUTABLE RISK; POTENTIALLY MODIFI ABLE RISK FACTOR; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX RATIO; SMOKING; SOCIAL PSYCHOLOGY; URINALYSIS; WAIST HIP RATIO; WESTERN HEMISPHERE; ADVERSE EFFECTS; ATRIAL FIBRILLATION; BLOOD; CEREBRAL HEMORRHAGE; CHINA; CLINICAL TRIAL; COMPLICATION; DIABETES COMPLICATIONS; DRINKING BEHAVIOR; EVIDENCE BASED MEDICINE; FEEDING BEHAVIOR; HEALTH BEHAVIOR; INTERNATIONAL COOPERATION; MOTOR ACTIVITY; MULTICENTER STUDY; OBESITY, ABDOMINAL; ODDS RATIO; PATHOLOGY; RISK REDUCTION; SELF REPORT; STROKE;

ADULT; AFRICA; AGED; ALCOHOL DRINKING; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; ASIA; ATRIAL FIBRILLATION; AUSTRALIA; BIOMARKERS; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBRAL HEMORRHAGE; CHINA; DIABETES COMPLICATIONS; EUROPE; EVIDENCE-BASED MEDICINE; FEMALE; FOOD HABITS; HEALTH BEHAVIOR; HUMANS; HYPERTENSION; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; MIDDLE EAST; MOTOR ACTIVITY; OBESITY, ABDOMINAL; ODDS RATIO; RISK FACTORS; RISK REDUCTION BEHAVIOR; SELF REPORT; SMOKING; STROKE; WAIST-HIP RATIO;

EID: 84991666872     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(16)30506-2     Document Type: Article

References (48)

1. 1 Feigin, VL, Mensah, GA, Norrving, B, Murray, CJ, Roth, GA, for the GBD 2013 Stroke Panel Experts Group. Atlas of the Global Burden of Stroke (1990–2013): the GBD 2013 Study. Neuroepidemiology 45 (2015), 230–236.
2. 2 Norrving, B, Davis, SM, Feigin, VL, et al. Stroke prevention worldwide-what could make it work?. Neuroepidemiology 45 (2015), 215–220.
3. 3 O'Donnell, MJ, Xavier, D, Liu, L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 376 (2010), 112–123.
4. 4 O'Donnell, M, Yusuf, S, Tackling the global burden of stroke: the need for large-scale international studies. Lancet Neurol 8 (2009), 306–307.
5. 5 Feigin, VL, Krishnamurthi, R, Bhattacharjee, R, et al. New strategy to reduce the global burden of stroke. Stroke 46 (2015), 1740–1747.
6. 6 Feigin, VL, Krishnamurthi, RV, Parmar, P, et al. Update on the global burden of ischemic and hemorrhagic stroke in 1990–2013: the GBD 2013 Study. Neuroepidemiology 45 (2015), 161–176.
7. 7 GBD 2013 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386 (2015), 2287–2323.
8. 8 Feigin, VL, Roth, GA, Naqhavi, M, et al. Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Neurol, 2016 published online June 9. http://dx.doi.org/10.1016/S1474-4422(16)30073-4.
9. 9 Yusuf, S, McKee, M, Documenting the global burden of cardiovascular disease: a major achievement but still a work in progress. Circulation 129 (2014), 1459–1462.
10. 10 O'Donnell, M, Xavier, D, Diener, C, et al. Rationale and design of INTERSTROKE: a global case-control study of risk factors for stroke. Neuroepidemiology 35 (2010), 36–44.
11. 11 Hatano, S, Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 54 (1976), 541–553.
12. 12 Bonita, R, Beaglehole, R, Recovery of motor function after stroke. Stroke 19 (1988), 1497–1500.
13. 13 Yusuf, S, Hawken, S, Ounpuu, S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004), 937–952.
14. 14 Fischer, U, Cooney, MT, Bull, LM, et al. Acute post-stroke blood pressure relative to premorbid levels in intracerebral haemorrhage versus major ischaemic stroke: a population-based study. Lancet Neurol 13 (2014), 374–384.
15. 15 Dehghan, M, Mente, A, Teo, KK, et al. Relationship between healthy diet and risk of cardiovascular disease among patients on drug therapies for secondary prevention: a prospective cohort study of 31 546 high-risk individuals from 40 countries. Circulation 126 (2012), 2705–2712.
16. 16 Chiuve, SE, Fung, TT, Rimm, EB, et al. Alternative dietary indices both strongly predict risk of chronic disease. J Nutr 142 (2012), 1009–1018.
17. 17 Smyth, A, Teo, KK, Rangarajan, S, et al. Alcohol consumption and cardiovascular disease, cancer, injury, admission to hospital, and mortality: a prospective cohort study. Lancet 386 (2015), 1945–1954.
18. 18 Benichou, J, Gail, MH, Variance calculations and confidence intervals for estimates of the attributable risk based on logistic models. Biometrics 46 (1990), 991–1003.
19. 19 Eide, GE, Heuch, I, Average attributable fractions: a coherent theory for apportioning excess risk to individual risk factors and subpopulations. Biom J 48 (2006), 820–837.
20. 20 Ferguson, J, Alvarez-Iglesias, A, Newell, J, Hinde, J, O'Donnell, M, Estimating average attributable fractions with confidence intervals for cohort and case–control studies. Stat Methods Med Res, 2016, 10.1177/0962280216655374 published online June 24.
21. 21 Peters, SA, Singhateh, Y, Mackay, D, Huxley, RR, Woodward, M, Total cholesterol as a risk factor for coronary heart disease and stroke in women compared with men: a systematic review and meta-analysis. Atherosclerosis 248 (2016), 123–131.
22. 22 Lock, K, Pomerleau, J, Causer, L, Altmann, DR, McKee, M, The global burden of disease attributable to low consumption of fruit and vegetables: implications for the global strategy on diet. Bull World Health Organ 83 (2005), 100–108.
23. 23 Kontogianni, MD, Panagiotakos, DB, Dietary patterns and stroke: a systematic review and re-meta-analysis. Maturitas 79 (2014), 41–47.
24. 24 Micha, R, Khatibzadeh, S, Shi, P, Andrews, KG, Engell, RE, Mozaffarian, D, Global, regional and national consumption of major food groups in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys worldwide. BMJ Open, 5, 2015, e008705.
25. 25 Singh, PN, Arthur, KN, Orlich, MJ, et al. Global epidemiology of obesity, vegetarian dietary patterns, and noncommunicable disease in Asian Indians. Am J Clin Nutr 100:suppl 1 (2014), 359S–364S.
26. 26 Leong, DP, Smyth, A, Teo, KK, et al. Patterns of alcohol consumption and myocardial infarction risk: observations from 52 countries in the INTERHEART case-control study. Circulation 130 (2014), 390–398.
27. 27 Chow, CK, Teo, KK, Rangarajan, S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 310 (2013), 959–968.
28. 28 Hyun, KK, Huxley, RR, Arima, H, et al. A comparative analysis of risk factors and stroke risk for Asian and non-Asian men: the Asia Pacific cohort studies collaboration. Int J Stroke 8 (2013), 606–611.
29. 29 Eastwood, SV, Tillin, T, Chaturvedi, N, Hughes, AD, Ethnic differences in associations between blood pressure and stroke in South Asian and European Men. Hypertension 66 (2015), 481–488.
30. 30 McGrath, ER, Kapral, MK, Fang, J, et al. Association of atrial fibrillation with mortality and disability after ischemic stroke. Neurology 81 (2013), 825–832.
31. 31 Vibha, D, Prasad, K, Cerebrovascular disease in South Asia—part II: risk factors and prevention. JRSM Cardiovasc Dis, 1, 2012, 21.
32. 32 Wang, C, Yang, Z, Wang, C, et al. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry. J Stroke Cerebrovasc Dis 23 (2014), 1157–1163.
33. 33 Saposnik, G, Del Brutto, OH, for the Iberoamerican Society of Cerebrovascular Diseases. Stroke in South America: a systematic review of incidence, prevalence, and stroke subtypes. Stroke 34 (2003), 2103–2107.
34. 34 Chugh, SS, Havmoeller, R, Narayanan, K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 129 (2014), 837–847.
35. 35 Rodriguez, CJ, Soliman, EZ, Alonso, A, et al. Atrial fibrillation incidence and risk factors in relation to race-ethnicity and the population attributable fraction of atrial fibrillation risk factors: the Multi-Ethnic Study of Atherosclerosis. Ann Epidemiol 25 (2015), 71–76.
36. 36 Huxley, RR, Hirakawa, Y, Hussain, MA, et al. Age- and sex-specific burden of cardiovascular disease attributable to 5 major and modifiable risk factors in 10 Asian countries of the Western Pacific region. Circ J 79 (2015), 1662–1674.
37. 37 Willey, JZ, Moon, YP, Kahn, E, et al. Population attributable risks of hypertension and diabetes for cardiovascular disease and stroke in the northern Manhattan study. J Am Heart Assoc, 3, 2014, e001106.
38. 38 Hajat, C, Tilling, K, Stewart, JA, Lemic-Stojcevic, N, Wolfe, CD, Ethnic differences in risk factors for ischemic stroke: a European case-control study. Stroke 35 (2004), 1562–1567.
39. 39 Bos, MJ, Koudstaal, PJ, Hofman, A, Ikram, MA, Modifiable etiological factors and the burden of stroke from the Rotterdam study: a population-based cohort study. PLoS Med, 11, 2014, e1001634.
40. 40 Poulter, NR, Prabhakaran, D, Caulfield, M, Hypertension. Lancet 386 (2015), 801–812.
41. 41 Andersen, KK, Olsen, TS, Dehlendorff, C, Kammersgaard, LP, Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors. Stroke 40 (2009), 2068–2072.
42. 42 Zhao, D, Liu, J, Wang, W, et al. Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICA-Beijing Project. Stroke 39 (2008), 1668–1674.
43. 43 Yusuf, S, Rangarajan, S, Teo, K, et al. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med 371 (2014), 818–827.
44. 44 Rowe, AK, Powell, KE, Flanders, WD, Why populations attributable fractions can sum to more than one. Am J Prev Med 365 (2004), 1434–1437.
45. 45 McQueen, MJ, Hawken, S, Wang, X, et al. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 372 (2008), 224–233.
46. 46 Gerstein, HC, Islam, S, Anand, S, et al. Dysglycaemia and the risk of acute myocardial infarction in multiple ethnic groups: an analysis of 15,780 patients from the INTERHEART study. Diabetologia 53 (2010), 2509–2517.
47. 47 Chen, Z, Chen, J, Collins, R, et al. China Kadoorie Biobank of 0·5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol 40 (2011), 1652–1666.
48. 48 Sudlow, C, Gallacher, J, Allen, N, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med, 12, 2015, e1001779.